Search Results - "Freynet, O"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Sarcoidosis and Emergency Hospitalization by Gazengel, Pierre, Hindre, R., Jeny, F., Mendes, S., Caliez, J., Freynet, O., Rotenberg, C., Didier, M., Dhote, R., Cohen, Y., Uzunhan, Y., Bouvry, D., Nunes, H.

    Published in Chest (28-08-2024)
    “…Sarcoidosis is an idiopathic systemic granulomatosis whose evolution is self-limiting in most cases. However, it can progress to organ damage that menaces the…”
    Get full text
    Journal Article
  2. 2

    Low-cost air quality portable sensors and their potential use in respiratory health by Sesé, L., Gille, T., Pau, G., Dessimond, B., Uzunhan, Y., Bouvry, D., Hervé, A., Didier, M., Kort, F., Freynet, O., Rotenberg, C., Jeny, F., Khamis, W., Hindre, R., Maesano, C. N., Planes, C., Nunes, H., Annesi-Maesano, I.

    “…Air pollution is an environmental risk for the general population and for patients with various diseases, particularly respiratory diseases. Little data are…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Two-year follow-up of 196 interstitial lung disease patients after ICU stay by Tandjaoui-Lambiotte, Y., Gonzalez, F., Boubaya, M., Freynet, O., Clec´h, C., Bonnet, N., Van Der Meersch, G., Oziel, J., Huang, C., Uzunhan, Y., Brillet, P-Y., Poirson, F., Martin, O., Ahmed, P., Ebstein, N., Karoubi, P., Gaudry, S., Nunes, H., Cohen, Y.

    “…OBJECTIVE: Interstitial lung diseases (ILDs) are associated with poor prognosis in the intensive care unit (ICU). We aimed to assess factors associated with…”
    Get full text
    Journal Article
  5. 5

    Treatment of sarcoidosis by Londner, C, Zendah, I, Freynet, O, Carton, Z, Dion, G, Nunes, H, Valeyre, D

    Published in La revue de medecine interne (01-02-2011)
    “…Sarcoidosis is a common disorder with heterogeneous severity. Corticosteroids are the cornerstone of its treatment and allow a disease remission but only with…”
    Get full text
    Journal Article
  6. 6

    Progression of idiopathic pulmonary fibrosis: lessons from asymmetrical disease by Tcherakian, Colas, Cottin, Vincent, Brillet, Pierre-Yves, Freynet, Olivia, Naggara, Nicolas, Carton, Zohra, Cordier, Jean-François, Brauner, Michel, Valeyre, Dominique, Nunes, Hilario

    Published in Thorax (01-03-2011)
    “…In idiopathic pulmonary fibrosis (IPF) the distribution and spatial-temporal progression of fibrotic changes may be influenced by general or locoregional…”
    Get more information
    Journal Article
  7. 7

    Dupilumab : une alternative à la corticothérapie pour l’Adult onset Asthma and PeriOcular Xanthogranuloma syndrome (AAPOXs) ? by Finet, F., Sese, L., Soussan, M., Uzunhan, Y., Freynet, O., Dhôte, R., Abad, S.

    Published in La revue de medecine interne (01-06-2024)
    “…L’AAPOX syndrome est une histiocytose non Langerhansienne rare, parfois associée à une maladie à IgG4 [1]. Ces deux maladies sont traitées en première ligne…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Tracheobronchial involvement in relapsing polychondritis and differential diagnoses by Grandière, L, Gille, T, Brillet, P-Y, Didier, M, Freynet, O, Vicaire, H, Clero, D, Martinod, E, Mathian, A, Uzunhan, Y

    Published in Revue des maladies respiratoires (01-06-2024)
    “…Relapsing polychondritis is a systemic auto-immune disease that mainly affects cartilage structures, progressing through inflammatory flare-ups between phases…”
    Get more information
    Journal Article
  10. 10

    Traitement de la sarcoïdose by Londner, C., Zendah, I., Freynet, O., Carton, Z., Dion, G., Nunes, H., Valeyre, D.

    Published in La revue de medecine interne (01-02-2011)
    “…La sévérité de la sarcoïdose est très variable. La corticothérapie en est le traitement de référence, permettant une rémission de la maladie avec un effet,…”
    Get full text
    Journal Article
  11. 11